chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 70.0
Sex: F
Vaccine: COVID19-2
Symptoms: Ultrasound Doppler abnormal
Clinical narrative: In December of 2022 my legs felt heavy to me when I would walk.  On January 29, 2023, I had severe pain in my right calf and my ankle and calf were noticeably swollen.  I recognized this as a possible DVT.  I went to visit the doctor on January 31, 2023.  I went to the emergency department and had an ultrasound and started me on Eliquis.  I saw a vascular surgeon on March 13th and was advised to stay on this medication for one year.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Anaemia, Coagulopathy
Clinical narrative: D68.9 COAGULOPATHY, UNSPECIFIED TYPE 4/14/2021 ANEMIA
Age: 89.0
Sex: M
Vaccine: COVID19
Symptoms: Peripheral swelling
Clinical narrative: The booster before my leg swelled up from my mid-calf down to my foot. I went to urgent care to get it checked.  There was no blockage of a blood clot. It subsided after being but on an antihistamine and Lasix. It was gone in 4 to 5 days I took Benadryl with this most recent dose to offset, this was on 10/06/2022 Lot# GH9693 Pfizer-Bivalent. The reaction was the same but not as severe. It down my leg between the knee and ankle. It was slight swelling, I reported to the doctor, and he told me take the medication I had before on the last dose. It helped and within 48 hours it was back down to normal size.
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: Cough, Nasal congestion, Nasopharyngitis, Respiratory symptom, Rhinorrhoea
Clinical narrative: On approximately, 01/15/2023, in the morning, I began to have head cold and upper respiratory symptoms. Each time, it resolves, then lasts another ten or so days. I have had nasal congestion, runny nose, cough, no fever. I am still having these symptoms, this is the third occurrence. I treat with NYQUIL and cough medicine. I went to my doctor a couple of days ago.
Age: 65.0
Sex: M
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test negative
Clinical narrative: On approximately, 01/15/2023, in the morning, I began to have head cold and upper respiratory symptoms. Each time, it resolves, then lasts another ten or so days. I have had nasal congestion, runny nose, cough, no fever. I am still having these symptoms, this is the third occurrence. I treat with NYQUIL and cough medicine. I went to my doctor a couple of days ago.
Age: 84.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Death, General physical health deterioration, Ischaemic stroke, Mental status changes
Clinical narrative: 3RD DOSE MODERNA COVID VACCINE GIVEN 10/18/21 #076C21A; 4TH DOSE MODERNA COVID VACCINE GIVEN 05/26/2022 #054A22A; pt had a recent hospitalization after an acute ischemic CVA, was dc'd to a rehab center; back to hospital on 10/18/22 with worsening mental status and high aspiration risk; pt continued to deteriorate; comfort measures; no interventions; pt passed away in the hospital
Age: 79.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Cardiac failure congestive, Condition aggravated, Deep vein thrombosis, Hypoxia
Clinical narrative: ACUTE DVT OF LEFT FEMORAL VEIN 3/5/2021 CHF EXACERBATION, UNSPECIFIED ACUTE RESPIRATORY FAILURE 3/5/2021 CHF EXACERBATION, UNSPECIFIED HYPOXIA 3/5/2021 CHF EXACERBATION, UNSPECIFIED
Age: 5.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: None:  Gave expired covid 19  shot. expired 10/25/2022. Given 1-9-2023
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, Respiratory distress
Clinical narrative: J96.00 ACUTE RESPIRATORY FAILURE 6/9/2021 ACUTE RESPIRATORY DISTRESS J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/30/2021 ACUTE RESPIRATORY DISTRESS
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Chest discomfort, Cough, Fatigue, Headache
Clinical narrative: I had a sore throat, a headache, fatigue, cough and tightness in my chest.
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Oropharyngeal pain, SARS-CoV-2 test positive
Clinical narrative: I had a sore throat, a headache, fatigue, cough and tightness in my chest.
Age: 68.0
Sex: F
Vaccine: COVID19-2, UNK
Symptoms: Dental cleaning, Lichen planus, Oral disorder, Oral surgery
Clinical narrative: 11/11/22 I had a normal cleaning check up with my Dentist. I had a lesion in my mouth that I was unaware of. The dentist said if it did not go away in two weeks, he would send me to an oral surgeon.  After two weeks, it had not gone away so I went to see an Oral Surgeon in December.  They did not think it was anything. In January 2023, I went back to the Oral Surgeon, and they removed the lesion and diagnosed me with Lichen Planus.
Age: 67.0
Sex: M
Vaccine: COVID19-2
Symptoms: Atrial fibrillation, Cardiac monitoring abnormal, Gastrointestinal disorder, Ventricular extrasystoles
Clinical narrative: I was having PVCs for a long time and got a device to monitor it. I had several moments of Atrial Fibrillation. and only had PVCs prior to being vaccinated. Now I am dealing with Atrial Fibrillation Then, on 10/25/22, It happened again, and I went to the Emergency Room. This lasted for 20 hours. This was two days before my vaccination. On 3/11/23, 3/22/23, 4/4/23 I had Atrial Fibrillation again. The one on 4/4/23 Lasted for about 10 hours. Then on 4/5/23, 4/6/23, 4/8/23, 4/9/23, it happened again. I had to be hospitalized with the incident on 4/9/23. I have a procedure happening soon. I am also having a lot of Gastrointestinal Issues.
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Chronic obstructive pulmonary disease, Condition aggravated, Coronary artery disease, Dyspnoea exertional
Clinical narrative: Patient was admitted meeting sepsis criteria and received antibiotics and IVF as well as breathing treatments, steroids, and remdesivir for COVID.  Patient's imaging and procalcitonin were not convincing of a bacterial infection and antibiotics were discontinued.  Patient returned to baseline home oxygen requirement and although he becomes very SOB with exertion, this is not abnormal for him.  Patient will be discharged home with prednisone 40mg daily x4 days and instructions to follow up with PCP and pulmonology.   Discharge diagnosis COVID-19 with hypoxia Sepsis COPD exacerbation Insulin-dependent diabetes CAD Hypertension Hyperlipidemia
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Hyperlipidaemia, Hypertension, Hypoxia, Imaging procedure, Procalcitonin
Clinical narrative: Patient was admitted meeting sepsis criteria and received antibiotics and IVF as well as breathing treatments, steroids, and remdesivir for COVID.  Patient's imaging and procalcitonin were not convincing of a bacterial infection and antibiotics were discontinued.  Patient returned to baseline home oxygen requirement and although he becomes very SOB with exertion, this is not abnormal for him.  Patient will be discharged home with prednisone 40mg daily x4 days and instructions to follow up with PCP and pulmonology.   Discharge diagnosis COVID-19 with hypoxia Sepsis COPD exacerbation Insulin-dependent diabetes CAD Hypertension Hyperlipidemia
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Sepsis, Type 1 diabetes mellitus
Clinical narrative: Patient was admitted meeting sepsis criteria and received antibiotics and IVF as well as breathing treatments, steroids, and remdesivir for COVID.  Patient's imaging and procalcitonin were not convincing of a bacterial infection and antibiotics were discontinued.  Patient returned to baseline home oxygen requirement and although he becomes very SOB with exertion, this is not abnormal for him.  Patient will be discharged home with prednisone 40mg daily x4 days and instructions to follow up with PCP and pulmonology.   Discharge diagnosis COVID-19 with hypoxia Sepsis COPD exacerbation Insulin-dependent diabetes CAD Hypertension Hyperlipidemia
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19 pneumonia, Hypoxia
Clinical narrative: R09.02 HYPOXIA 1/8/2022 COVID-19 PNEUMONIA
Age: 43.0
Sex: F
Vaccine: COVID19-2
Symptoms: Adenomyosis, Biopsy uterus abnormal, Dysmenorrhoea, Heavy menstrual bleeding, Iron deficiency anaemia
Clinical narrative: I had an extremely heavy lost of blood from menstrual cycle, with big blood clothes as big as 4 inches in diameter. Also, very painful cramps and very heavy and long periods. I saw my doctor, they did a biopsy  and ultrasound they diagnosed me with iron deficiency anemia which is adenomyosis.
Age: 43.0
Sex: F
Vaccine: COVID19-2
Symptoms: Menstrual clots, Pain, Ultrasound uterus abnormal
Clinical narrative: I had an extremely heavy lost of blood from menstrual cycle, with big blood clothes as big as 4 inches in diameter. Also, very painful cramps and very heavy and long periods. I saw my doctor, they did a biopsy  and ultrasound they diagnosed me with iron deficiency anemia which is adenomyosis.
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Abnormal uterine bleeding, Acute respiratory failure, Anxiety, Atrial fibrillation, Coagulopathy
Clinical narrative: D68.9 ABNL UTERINE BLEEDING DUE TO COAGULOPATHY 2/19/2022 HX OF CARDIOVERSION I26.99 ACUTE PULMONARY EMBOLISM 2/23/2022 HX OF CARDIOVERSION J96.00 ACUTE RESPIRATORY FAILURE 1/11/2022 HX OF CARDIOVERSION J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 2/23/2022 HX OF CARDIOVERSION J96.91 HYPOXEMIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 2/23/2022 HX OF CARDIOVERSION D68.9 ABNL UTERINE BLEEDING DUE TO COAGULOPATHY 2/19/2022 ATRIAL FIBRILLATION, UNSPECIFIED I26.99 ACUTE PULMONARY EMBOLISM 2/23/2022 ATRIAL FIBRILLATION, UNSPECIFIED J96.00 ACUTE RESPIRATORY FAILURE 1/11/2022 ATRIAL FIBRILLATION, UNSPECIFIED J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 2/23/2022 ATRIAL FIBRILLATION, UNSPECIFIED J96.91 HYPOXEMIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 2/23/2022 ATRIAL FIBRILLATION, UNSPECIFIED D68.9 ABNL UTERINE BLEEDING DUE TO COAGULOPATHY 2/19/2022 UNSPECIFIED ANXIETY I26.99 ACUTE PULMONARY EMBOLISM 2/23/2022 UNSPECIFIED ANXIETY J96.00 ACUTE RESPIRATORY FAILURE 1/11/2022 UNSPECIFIED ANXIETY J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 2/23/2022 UNSPECIFIED ANXIETY J96.91 HYPOXEMIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 2/23/2022 UNSPECIFIED ANXIETY D68.9 ABNL UTERINE BLEEDING DUE TO COAGULOPATHY 2/19/2022 ACUTE RESPIRATORY FAILURE I26.99 ACUTE PULMONARY EMBOLISM 2/23/2022 ACUTE RESPIRATORY FAILURE J96.00 ACUTE RESPIRATORY FAILURE 1/11/2022 ACUTE RESPIRATORY FAILURE J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 2/23/2022 ACUTE RESPIRATORY FAILURE J96.91 HYPOXEMIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 2/23/2022 ACUTE RESPIRATORY FAILURE
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Pulmonary embolism, Respiratory failure
Clinical narrative: D68.9 ABNL UTERINE BLEEDING DUE TO COAGULOPATHY 2/19/2022 HX OF CARDIOVERSION I26.99 ACUTE PULMONARY EMBOLISM 2/23/2022 HX OF CARDIOVERSION J96.00 ACUTE RESPIRATORY FAILURE 1/11/2022 HX OF CARDIOVERSION J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 2/23/2022 HX OF CARDIOVERSION J96.91 HYPOXEMIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 2/23/2022 HX OF CARDIOVERSION D68.9 ABNL UTERINE BLEEDING DUE TO COAGULOPATHY 2/19/2022 ATRIAL FIBRILLATION, UNSPECIFIED I26.99 ACUTE PULMONARY EMBOLISM 2/23/2022 ATRIAL FIBRILLATION, UNSPECIFIED J96.00 ACUTE RESPIRATORY FAILURE 1/11/2022 ATRIAL FIBRILLATION, UNSPECIFIED J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 2/23/2022 ATRIAL FIBRILLATION, UNSPECIFIED J96.91 HYPOXEMIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 2/23/2022 ATRIAL FIBRILLATION, UNSPECIFIED D68.9 ABNL UTERINE BLEEDING DUE TO COAGULOPATHY 2/19/2022 UNSPECIFIED ANXIETY I26.99 ACUTE PULMONARY EMBOLISM 2/23/2022 UNSPECIFIED ANXIETY J96.00 ACUTE RESPIRATORY FAILURE 1/11/2022 UNSPECIFIED ANXIETY J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 2/23/2022 UNSPECIFIED ANXIETY J96.91 HYPOXEMIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 2/23/2022 UNSPECIFIED ANXIETY D68.9 ABNL UTERINE BLEEDING DUE TO COAGULOPATHY 2/19/2022 ACUTE RESPIRATORY FAILURE I26.99 ACUTE PULMONARY EMBOLISM 2/23/2022 ACUTE RESPIRATORY FAILURE J96.00 ACUTE RESPIRATORY FAILURE 1/11/2022 ACUTE RESPIRATORY FAILURE J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 2/23/2022 ACUTE RESPIRATORY FAILURE J96.91 HYPOXEMIC RESPIRATORY FAILURE, UNSPECIFIED ACUITY 2/23/2022 ACUTE RESPIRATORY FAILURE
Age: 6.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: None COVID -19 EXPIRED 10/25/2022 GIVEN 01/06/2023
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dizziness, Heart rate decreased, Heart rate irregular, SARS-CoV-2 test negative
Clinical narrative: Last month on 03/2023 I started experiencing lightheadedness and my heart rate was low although, my blood pressure was normal. I've noticed on the machine I was having irregular heartbeat. I was so concerned that I scheduled an appointment with my doctor on 03/27/2023. Since my regular doctor wasn't available I was seen by her assistant. She did an examination. She also decreased my medication metoprolol to 20mg. I stopped taking tizanidine. I stated feeling better afterwards. Am going back to my doctor on 04/28/2023 again for a follow up. My doctor might take me off amlodipine. All the medications have the tendency to have irregular heartbeat so I am trying to avoid as much.
Age: 19.0
Sex: F
Vaccine: MNQ, HEP, MNQ
Symptoms: Extra dose administered, Hepatitis B antibody negative, Wrong product administered
Clinical narrative: Pt came in for vaccine appointment, needing Hep B #2 after restarting series after found to be non-immune on labs. Instead of receiving Hep B #2 an extra third dose of MenQuanfi given by nursing shift.
Age: 19.0
Sex: F
Vaccine: MNQ, HEP, MNQ
Symptoms: Wrong product administered
Clinical narrative: Pt came in for vaccine appointment, needing Hep B #2 after restarting series after found to be non-immune on labs. Instead of receiving Hep B #2 an extra third dose of MenQuanfi given by nursing shift.
Age: 19.0
Sex: F
Vaccine: MNQ, HEP, MNQ
Symptoms: Extra dose administered, Hepatitis B antibody negative, Wrong product administered
Clinical narrative: PATIENT CAME FOR HEP B SERIES , AND RCEIVED MENQUADFI
Age: 19.0
Sex: F
Vaccine: MNQ, HEP, MNQ
Symptoms: Wrong product administered
Clinical narrative: PATIENT CAME FOR HEP B SERIES , AND RCEIVED MENQUADFI
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Oropharyngeal pain, Pain, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: I experienced a breakthrough case of COVID-19 with aches, sore throat, bed rest for a few days. 5 days later I tested negative.
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Chills, Dizziness, Erythema, Laboratory test, Lethargy
Clinical narrative: light headed  chills muscle hurts lathargic  this one is worst than the last time. Taken to the ER 2 days after. They think its vertigo. The minute the selling went down on my arm the  light headed went away and my arm was really red.   ER info: just there for 6 hrs
Age: 65.0
Sex: F
Vaccine: VARZOS
Symptoms: Myalgia, Peripheral swelling
Clinical narrative: light headed  chills muscle hurts lathargic  this one is worst than the last time. Taken to the ER 2 days after. They think its vertigo. The minute the selling went down on my arm the  light headed went away and my arm was really red.   ER info: just there for 6 hrs
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Echocardiogram abnormal, Hiccups, Myocardial infarction, Visual impairment
Clinical narrative: I was diagnosed with a mild heart attack on February 9, 2023 I was having issues with my vision and it felt like I having hiccups in my chest. No blockage.
Age: 2.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: fever upto 104 within 1hr of vaccine, fever still present at 24hrs- otherwise normal exam on 4/14/2023
Age: 8.0
Sex: M
Vaccine: COVID19-2
Symptoms: Unevaluable event
Clinical narrative: None yet.
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Feeling abnormal, Headache, Oropharyngeal pain
Clinical narrative: No adverse reaction after the vaccine on sept of last year. I got COVID-19 and it was Positive; headache, sore throat, cough, body ache, ended with fever the next day, did not feel good. I called the clinic, and they referred to the pharmacy and they gave me Paxlovid. I pick it up and started taking it that night. I finished it after 5 days (the 13th). I felt better at the end of the treatment. I waited 10 days and came back Positive, so I waited another 10 days, and it came negative, 48 hrs I took another test and it negative. I followed procedals.
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: Pain, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: No adverse reaction after the vaccine on sept of last year. I got COVID-19 and it was Positive; headache, sore throat, cough, body ache, ended with fever the next day, did not feel good. I called the clinic, and they referred to the pharmacy and they gave me Paxlovid. I pick it up and started taking it that night. I finished it after 5 days (the 13th). I felt better at the end of the treatment. I waited 10 days and came back Positive, so I waited another 10 days, and it came negative, 48 hrs I took another test and it negative. I followed procedals.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Blood sodium decreased, C-reactive protein increased, COVID-19, Chest X-ray normal, Chills
Clinical narrative: Patient is a 84 y.o. male patient of, MD with history of spinal cord stroke, history of chronic tracheostomy and chronic hypoxic respiratory failure, PEG tube, DVTs, type 2 diabetes mellitus insulin requiring, hypertension, PUD, chronic anemia, hyperlipidemia and sacral and heel wounds who presented to Hospital with fevers, found to have COVID.   Sepsis Chronic hypotension COVID-19 Virus Infection Date of onset of symptoms: 3/25/23 Symptoms present on admission: Subjective fevers, chills, diaphoresis Date of covid positive test: 3/27/23 Vaccination status: vaccinated with booster Imaging: CXR with no acute process Oxygen requirements on admission: Room air Current oxygen requirements: Room air Medical therapy: unable to use paxlovid as cannot be crushed for PEG therefore started on remdesivir by ID as high risk for severe disease, completed 3 doses and after discussion with patient/family given that patient is doing well and wants to leave hospital, will discharge after 3 doses CRP elevated to 117, procal negative Consultants followed: ID Anticipated special isolation end date: 10 days after symptom onset   Hyponatremia Sodium of 131 on admission with element of dehydration Improved with IV fluids   History of tracheostomy Chronic respiratory failure with hypoxia Patient has been on room air for the past several months and doing well, no subjective shortness of breath CXR no acute process Monitor given COVID as high risk   History of CVA Chronic PEG Tube History of spinal cord and medullary/cerebellar infarcts History of CVA, initially on DAPT and no only on coumadin due to history of GIB Previously noted to be on tracheostomy with supplemental oxygen but recently noted to weaned down to RA On PEG tube, continue tube feeds and warfarin   Elevated LFTs Minimally, likely mild viral hepatitis from COVID vs possibly due to remdesivir Repeat LFTs 3-4 days   IDDM2 Home regimen of Lantus 14 units + SSI TIDAC Resume home regimen on discharge   History of DVT Diagnosed in Sept 2022 with DVT to LLE and LUE and SVT Continue home warfarin    Sacral/Coccyx Pressure Wound, POA  Left Heel Wound, POA  Wound care
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Condition aggravated, Decubitus ulcer, Dehydration, Hepatitis viral, Hyperhidrosis
Clinical narrative: Patient is a 84 y.o. male patient of, MD with history of spinal cord stroke, history of chronic tracheostomy and chronic hypoxic respiratory failure, PEG tube, DVTs, type 2 diabetes mellitus insulin requiring, hypertension, PUD, chronic anemia, hyperlipidemia and sacral and heel wounds who presented to Hospital with fevers, found to have COVID.   Sepsis Chronic hypotension COVID-19 Virus Infection Date of onset of symptoms: 3/25/23 Symptoms present on admission: Subjective fevers, chills, diaphoresis Date of covid positive test: 3/27/23 Vaccination status: vaccinated with booster Imaging: CXR with no acute process Oxygen requirements on admission: Room air Current oxygen requirements: Room air Medical therapy: unable to use paxlovid as cannot be crushed for PEG therefore started on remdesivir by ID as high risk for severe disease, completed 3 doses and after discussion with patient/family given that patient is doing well and wants to leave hospital, will discharge after 3 doses CRP elevated to 117, procal negative Consultants followed: ID Anticipated special isolation end date: 10 days after symptom onset   Hyponatremia Sodium of 131 on admission with element of dehydration Improved with IV fluids   History of tracheostomy Chronic respiratory failure with hypoxia Patient has been on room air for the past several months and doing well, no subjective shortness of breath CXR no acute process Monitor given COVID as high risk   History of CVA Chronic PEG Tube History of spinal cord and medullary/cerebellar infarcts History of CVA, initially on DAPT and no only on coumadin due to history of GIB Previously noted to be on tracheostomy with supplemental oxygen but recently noted to weaned down to RA On PEG tube, continue tube feeds and warfarin   Elevated LFTs Minimally, likely mild viral hepatitis from COVID vs possibly due to remdesivir Repeat LFTs 3-4 days   IDDM2 Home regimen of Lantus 14 units + SSI TIDAC Resume home regimen on discharge   History of DVT Diagnosed in Sept 2022 with DVT to LLE and LUE and SVT Continue home warfarin    Sacral/Coccyx Pressure Wound, POA  Left Heel Wound, POA  Wound care
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Hyponatraemia, Hypotension, Liver function test increased, Procalcitonin normal, Pyrexia
Clinical narrative: Patient is a 84 y.o. male patient of, MD with history of spinal cord stroke, history of chronic tracheostomy and chronic hypoxic respiratory failure, PEG tube, DVTs, type 2 diabetes mellitus insulin requiring, hypertension, PUD, chronic anemia, hyperlipidemia and sacral and heel wounds who presented to Hospital with fevers, found to have COVID.   Sepsis Chronic hypotension COVID-19 Virus Infection Date of onset of symptoms: 3/25/23 Symptoms present on admission: Subjective fevers, chills, diaphoresis Date of covid positive test: 3/27/23 Vaccination status: vaccinated with booster Imaging: CXR with no acute process Oxygen requirements on admission: Room air Current oxygen requirements: Room air Medical therapy: unable to use paxlovid as cannot be crushed for PEG therefore started on remdesivir by ID as high risk for severe disease, completed 3 doses and after discussion with patient/family given that patient is doing well and wants to leave hospital, will discharge after 3 doses CRP elevated to 117, procal negative Consultants followed: ID Anticipated special isolation end date: 10 days after symptom onset   Hyponatremia Sodium of 131 on admission with element of dehydration Improved with IV fluids   History of tracheostomy Chronic respiratory failure with hypoxia Patient has been on room air for the past several months and doing well, no subjective shortness of breath CXR no acute process Monitor given COVID as high risk   History of CVA Chronic PEG Tube History of spinal cord and medullary/cerebellar infarcts History of CVA, initially on DAPT and no only on coumadin due to history of GIB Previously noted to be on tracheostomy with supplemental oxygen but recently noted to weaned down to RA On PEG tube, continue tube feeds and warfarin   Elevated LFTs Minimally, likely mild viral hepatitis from COVID vs possibly due to remdesivir Repeat LFTs 3-4 days   IDDM2 Home regimen of Lantus 14 units + SSI TIDAC Resume home regimen on discharge   History of DVT Diagnosed in Sept 2022 with DVT to LLE and LUE and SVT Continue home warfarin    Sacral/Coccyx Pressure Wound, POA  Left Heel Wound, POA  Wound care
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sepsis, Wound treatment
Clinical narrative: Patient is a 84 y.o. male patient of, MD with history of spinal cord stroke, history of chronic tracheostomy and chronic hypoxic respiratory failure, PEG tube, DVTs, type 2 diabetes mellitus insulin requiring, hypertension, PUD, chronic anemia, hyperlipidemia and sacral and heel wounds who presented to Hospital with fevers, found to have COVID.   Sepsis Chronic hypotension COVID-19 Virus Infection Date of onset of symptoms: 3/25/23 Symptoms present on admission: Subjective fevers, chills, diaphoresis Date of covid positive test: 3/27/23 Vaccination status: vaccinated with booster Imaging: CXR with no acute process Oxygen requirements on admission: Room air Current oxygen requirements: Room air Medical therapy: unable to use paxlovid as cannot be crushed for PEG therefore started on remdesivir by ID as high risk for severe disease, completed 3 doses and after discussion with patient/family given that patient is doing well and wants to leave hospital, will discharge after 3 doses CRP elevated to 117, procal negative Consultants followed: ID Anticipated special isolation end date: 10 days after symptom onset   Hyponatremia Sodium of 131 on admission with element of dehydration Improved with IV fluids   History of tracheostomy Chronic respiratory failure with hypoxia Patient has been on room air for the past several months and doing well, no subjective shortness of breath CXR no acute process Monitor given COVID as high risk   History of CVA Chronic PEG Tube History of spinal cord and medullary/cerebellar infarcts History of CVA, initially on DAPT and no only on coumadin due to history of GIB Previously noted to be on tracheostomy with supplemental oxygen but recently noted to weaned down to RA On PEG tube, continue tube feeds and warfarin   Elevated LFTs Minimally, likely mild viral hepatitis from COVID vs possibly due to remdesivir Repeat LFTs 3-4 days   IDDM2 Home regimen of Lantus 14 units + SSI TIDAC Resume home regimen on discharge   History of DVT Diagnosed in Sept 2022 with DVT to LLE and LUE and SVT Continue home warfarin    Sacral/Coccyx Pressure Wound, POA  Left Heel Wound, POA  Wound care
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Hyperhidrosis, Oropharyngeal pain, Paranasal sinus hypersecretion
Clinical narrative: I started out with chills, then I had lots of sweating and sore throat.  I did a COVID-19 rapid test and it was positive on 03/26/2023.  I still have sinus drainage and still have a sore throat today.  I received treatment of Paxlovid which I started taking on 03/27/2023 and this was prescribed by my doctor.
Age: 62.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I started out with chills, then I had lots of sweating and sore throat.  I did a COVID-19 rapid test and it was positive on 03/26/2023.  I still have sinus drainage and still have a sore throat today.  I received treatment of Paxlovid which I started taking on 03/27/2023 and this was prescribed by my doctor.
Age: 5.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered
Clinical narrative: None Covid -19 vaccine expired 10/25/2022 given 01/06/2023
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Fatigue, Influenza like illness, Nasopharyngitis, Pain
Clinical narrative: My symptoms began with sneezing on February 11, 2023. I tested positive for COVID-19. I had flu-like symptoms. I began PAXLOVID on February 15, 2023. My toes were purple in color, and I noticed my hands were white. I had body aches and congestion. I was fatigued for a quite a few weeks. I got rebound symptoms. I didn't have flu-like symptoms mainly with cold symptoms. I have just now started to feel better.
Age: 71.0
Sex: M
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Skin discolouration, Sneezing
Clinical narrative: My symptoms began with sneezing on February 11, 2023. I tested positive for COVID-19. I had flu-like symptoms. I began PAXLOVID on February 15, 2023. My toes were purple in color, and I noticed my hands were white. I had body aches and congestion. I was fatigued for a quite a few weeks. I got rebound symptoms. I didn't have flu-like symptoms mainly with cold symptoms. I have just now started to feel better.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Epistaxis, Rhinorrhoea
Clinical narrative: nose bleed - not a major gush, just when I blew my nose due to allergies/chronic runny nose, I saw blood in the tissue - lasted about 2 days
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, COVID-19, Headache, Nasal congestion, SARS-CoV-2 test positive
Clinical narrative: I had joint pain in my knee after receiving the vaccine. I tested positive for COVID-19 on 02/23/2023.  My main complaint was having a headache. I also had a stuffy and congestion nose. I did not contact my doctor and I took either Tylenol or Advil as needed. As of today, I do not have any lingering symptoms of COVID-19.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Axillary mass, Computerised tomogram, Injection site pruritus, Injection site rash, Pruritus
Clinical narrative: Large lump in arm pit, rash and itching in left arm around injection site and down into wrist.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Rash
Clinical narrative: Large lump in arm pit, rash and itching in left arm around injection site and down into wrist.
Age: 55.0
Sex: F
Vaccine: COVID19-2
Symptoms: Extra dose administered
Clinical narrative: Provider asked me to give a Bivalent Pfizer vaccine to patient. Vaccine was given by protocol.  I checked the selection that said she had not had a previous bivalent vaccine, as I made a mistake and did not see that she had already had a previous one.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Acute kidney injury, Acute respiratory failure, Anaemia, Angiogram pulmonary abnormal, Blood creatinine increased
Clinical narrative: Patient is a 54 y.o. male patient of MD with history of hypertension who presented to Hospital with shortness of breath, fatigue, recent COVID positive home test, found to have multifactorial pneumonia.   Acute respiratory failure with hypoxemia Abnormal CT chest  Multifocal pneumonia Respiratory failure in setting of pneumonia, likely combination of bacterial with component of COVID CTPA on admission without PE, though showed extensive bilateral lung opacity involving all lobes, most confluent in the left lung Initially required 4L supplemental O2, weaned to room air quickly Urinary antigens negative Sputum culture with mixed flora MRSA swab negative Pulm followed Initially on vanc/zosyn, transitioned to levofloxacin, planning 7 day course total Repeat CT chest in 6-8 weeks with outpatient pulmonology follow up   Sepsis, POA Lactic acidosis Due to pneumonia with leukocytosis, tachycardia, lactic acidosis on admission Blood cultures 2/2 with staph hominis, suspect contaminant Repeat blood cultures without growth at 48 hours Treated with antibiotics as above   CoNS positive blood cultures Blood cultures on admission 2 of 2 staph hominis, thought to be both contaminants given collection timing and not clinically relevant TTE does not show evidence of endocarditis ID followed Repeat blood cultures negative at 48 hours   Covid-19 Virus Infection Date of onset of symptoms: 3/10 Symptoms present on admission: Shortness of breath, fatigue Date of covid positive test: 3/12 on home antigen test, 3/15 here Vaccination status: vaccinated without booster Imaging: CTPA as above Oxygen requirements on admission: 4L nasal cannula Current oxygen requirements: room air Medical therapy: received steroids while admitted, discontinued on discharge given on room air and only briefly required oxygen;, was taking Paxlovid at home Consultants following: pulm Anticipated special isolation end date: 3/20   AKI Metabolic acidosis Admit Cr 2.1, baseline normal, suspect prerenal with ACEi use and was taking Paxlovid Improved renal function, back to baseline Resume ACEi/diuretic on discharge   Elevated LFTs In setting of COVID, though possibly related to remdesivir Improved to near normal Repeat 1 week   Hyponatremia Na 123, in setting of diminished intake, but was 126 Normalized   Anemia, normocytic Hgb 12.5, baseline wnl  Without evidence of active bleeding Iron studies with anemia of chronic disease Repeat as outpatient   Essential hypertension  Home regimen: amlodipine and lisinopril/hydrochlorothiazide  Held ACEi/diuretic during admission Resume home regimen on discharge
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Blood iron, Blood sodium decreased, COVID-19, COVID-19 pneumonia, Computerised tomogram thorax abnormal
Clinical narrative: Patient is a 54 y.o. male patient of MD with history of hypertension who presented to Hospital with shortness of breath, fatigue, recent COVID positive home test, found to have multifactorial pneumonia.   Acute respiratory failure with hypoxemia Abnormal CT chest  Multifocal pneumonia Respiratory failure in setting of pneumonia, likely combination of bacterial with component of COVID CTPA on admission without PE, though showed extensive bilateral lung opacity involving all lobes, most confluent in the left lung Initially required 4L supplemental O2, weaned to room air quickly Urinary antigens negative Sputum culture with mixed flora MRSA swab negative Pulm followed Initially on vanc/zosyn, transitioned to levofloxacin, planning 7 day course total Repeat CT chest in 6-8 weeks with outpatient pulmonology follow up   Sepsis, POA Lactic acidosis Due to pneumonia with leukocytosis, tachycardia, lactic acidosis on admission Blood cultures 2/2 with staph hominis, suspect contaminant Repeat blood cultures without growth at 48 hours Treated with antibiotics as above   CoNS positive blood cultures Blood cultures on admission 2 of 2 staph hominis, thought to be both contaminants given collection timing and not clinically relevant TTE does not show evidence of endocarditis ID followed Repeat blood cultures negative at 48 hours   Covid-19 Virus Infection Date of onset of symptoms: 3/10 Symptoms present on admission: Shortness of breath, fatigue Date of covid positive test: 3/12 on home antigen test, 3/15 here Vaccination status: vaccinated without booster Imaging: CTPA as above Oxygen requirements on admission: 4L nasal cannula Current oxygen requirements: room air Medical therapy: received steroids while admitted, discontinued on discharge given on room air and only briefly required oxygen;, was taking Paxlovid at home Consultants following: pulm Anticipated special isolation end date: 3/20   AKI Metabolic acidosis Admit Cr 2.1, baseline normal, suspect prerenal with ACEi use and was taking Paxlovid Improved renal function, back to baseline Resume ACEi/diuretic on discharge   Elevated LFTs In setting of COVID, though possibly related to remdesivir Improved to near normal Repeat 1 week   Hyponatremia Na 123, in setting of diminished intake, but was 126 Normalized   Anemia, normocytic Hgb 12.5, baseline wnl  Without evidence of active bleeding Iron studies with anemia of chronic disease Repeat as outpatient   Essential hypertension  Home regimen: amlodipine and lisinopril/hydrochlorothiazide  Held ACEi/diuretic during admission Resume home regimen on discharge
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Echocardiogram, Fatigue, Haemoglobin decreased, Hyponatraemia
Clinical narrative: Patient is a 54 y.o. male patient of MD with history of hypertension who presented to Hospital with shortness of breath, fatigue, recent COVID positive home test, found to have multifactorial pneumonia.   Acute respiratory failure with hypoxemia Abnormal CT chest  Multifocal pneumonia Respiratory failure in setting of pneumonia, likely combination of bacterial with component of COVID CTPA on admission without PE, though showed extensive bilateral lung opacity involving all lobes, most confluent in the left lung Initially required 4L supplemental O2, weaned to room air quickly Urinary antigens negative Sputum culture with mixed flora MRSA swab negative Pulm followed Initially on vanc/zosyn, transitioned to levofloxacin, planning 7 day course total Repeat CT chest in 6-8 weeks with outpatient pulmonology follow up   Sepsis, POA Lactic acidosis Due to pneumonia with leukocytosis, tachycardia, lactic acidosis on admission Blood cultures 2/2 with staph hominis, suspect contaminant Repeat blood cultures without growth at 48 hours Treated with antibiotics as above   CoNS positive blood cultures Blood cultures on admission 2 of 2 staph hominis, thought to be both contaminants given collection timing and not clinically relevant TTE does not show evidence of endocarditis ID followed Repeat blood cultures negative at 48 hours   Covid-19 Virus Infection Date of onset of symptoms: 3/10 Symptoms present on admission: Shortness of breath, fatigue Date of covid positive test: 3/12 on home antigen test, 3/15 here Vaccination status: vaccinated without booster Imaging: CTPA as above Oxygen requirements on admission: 4L nasal cannula Current oxygen requirements: room air Medical therapy: received steroids while admitted, discontinued on discharge given on room air and only briefly required oxygen;, was taking Paxlovid at home Consultants following: pulm Anticipated special isolation end date: 3/20   AKI Metabolic acidosis Admit Cr 2.1, baseline normal, suspect prerenal with ACEi use and was taking Paxlovid Improved renal function, back to baseline Resume ACEi/diuretic on discharge   Elevated LFTs In setting of COVID, though possibly related to remdesivir Improved to near normal Repeat 1 week   Hyponatremia Na 123, in setting of diminished intake, but was 126 Normalized   Anemia, normocytic Hgb 12.5, baseline wnl  Without evidence of active bleeding Iron studies with anemia of chronic disease Repeat as outpatient   Essential hypertension  Home regimen: amlodipine and lisinopril/hydrochlorothiazide  Held ACEi/diuretic during admission Resume home regimen on discharge
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Lactic acidosis, Leukocytosis, Liver function test increased, Lung opacity, Malaise
Clinical narrative: Patient is a 54 y.o. male patient of MD with history of hypertension who presented to Hospital with shortness of breath, fatigue, recent COVID positive home test, found to have multifactorial pneumonia.   Acute respiratory failure with hypoxemia Abnormal CT chest  Multifocal pneumonia Respiratory failure in setting of pneumonia, likely combination of bacterial with component of COVID CTPA on admission without PE, though showed extensive bilateral lung opacity involving all lobes, most confluent in the left lung Initially required 4L supplemental O2, weaned to room air quickly Urinary antigens negative Sputum culture with mixed flora MRSA swab negative Pulm followed Initially on vanc/zosyn, transitioned to levofloxacin, planning 7 day course total Repeat CT chest in 6-8 weeks with outpatient pulmonology follow up   Sepsis, POA Lactic acidosis Due to pneumonia with leukocytosis, tachycardia, lactic acidosis on admission Blood cultures 2/2 with staph hominis, suspect contaminant Repeat blood cultures without growth at 48 hours Treated with antibiotics as above   CoNS positive blood cultures Blood cultures on admission 2 of 2 staph hominis, thought to be both contaminants given collection timing and not clinically relevant TTE does not show evidence of endocarditis ID followed Repeat blood cultures negative at 48 hours   Covid-19 Virus Infection Date of onset of symptoms: 3/10 Symptoms present on admission: Shortness of breath, fatigue Date of covid positive test: 3/12 on home antigen test, 3/15 here Vaccination status: vaccinated without booster Imaging: CTPA as above Oxygen requirements on admission: 4L nasal cannula Current oxygen requirements: room air Medical therapy: received steroids while admitted, discontinued on discharge given on room air and only briefly required oxygen;, was taking Paxlovid at home Consultants following: pulm Anticipated special isolation end date: 3/20   AKI Metabolic acidosis Admit Cr 2.1, baseline normal, suspect prerenal with ACEi use and was taking Paxlovid Improved renal function, back to baseline Resume ACEi/diuretic on discharge   Elevated LFTs In setting of COVID, though possibly related to remdesivir Improved to near normal Repeat 1 week   Hyponatremia Na 123, in setting of diminished intake, but was 126 Normalized   Anemia, normocytic Hgb 12.5, baseline wnl  Without evidence of active bleeding Iron studies with anemia of chronic disease Repeat as outpatient   Essential hypertension  Home regimen: amlodipine and lisinopril/hydrochlorothiazide  Held ACEi/diuretic during admission Resume home regimen on discharge
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Metabolic acidosis, Pneumonia, Pneumonia bacterial, Renal impairment, SARS-CoV-2 test positive
Clinical narrative: Patient is a 54 y.o. male patient of MD with history of hypertension who presented to Hospital with shortness of breath, fatigue, recent COVID positive home test, found to have multifactorial pneumonia.   Acute respiratory failure with hypoxemia Abnormal CT chest  Multifocal pneumonia Respiratory failure in setting of pneumonia, likely combination of bacterial with component of COVID CTPA on admission without PE, though showed extensive bilateral lung opacity involving all lobes, most confluent in the left lung Initially required 4L supplemental O2, weaned to room air quickly Urinary antigens negative Sputum culture with mixed flora MRSA swab negative Pulm followed Initially on vanc/zosyn, transitioned to levofloxacin, planning 7 day course total Repeat CT chest in 6-8 weeks with outpatient pulmonology follow up   Sepsis, POA Lactic acidosis Due to pneumonia with leukocytosis, tachycardia, lactic acidosis on admission Blood cultures 2/2 with staph hominis, suspect contaminant Repeat blood cultures without growth at 48 hours Treated with antibiotics as above   CoNS positive blood cultures Blood cultures on admission 2 of 2 staph hominis, thought to be both contaminants given collection timing and not clinically relevant TTE does not show evidence of endocarditis ID followed Repeat blood cultures negative at 48 hours   Covid-19 Virus Infection Date of onset of symptoms: 3/10 Symptoms present on admission: Shortness of breath, fatigue Date of covid positive test: 3/12 on home antigen test, 3/15 here Vaccination status: vaccinated without booster Imaging: CTPA as above Oxygen requirements on admission: 4L nasal cannula Current oxygen requirements: room air Medical therapy: received steroids while admitted, discontinued on discharge given on room air and only briefly required oxygen;, was taking Paxlovid at home Consultants following: pulm Anticipated special isolation end date: 3/20   AKI Metabolic acidosis Admit Cr 2.1, baseline normal, suspect prerenal with ACEi use and was taking Paxlovid Improved renal function, back to baseline Resume ACEi/diuretic on discharge   Elevated LFTs In setting of COVID, though possibly related to remdesivir Improved to near normal Repeat 1 week   Hyponatremia Na 123, in setting of diminished intake, but was 126 Normalized   Anemia, normocytic Hgb 12.5, baseline wnl  Without evidence of active bleeding Iron studies with anemia of chronic disease Repeat as outpatient   Essential hypertension  Home regimen: amlodipine and lisinopril/hydrochlorothiazide  Held ACEi/diuretic during admission Resume home regimen on discharge
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Sepsis, Sputum culture positive, Staphylococcus test negative, Staphylococcus test positive, Tachycardia
Clinical narrative: Patient is a 54 y.o. male patient of MD with history of hypertension who presented to Hospital with shortness of breath, fatigue, recent COVID positive home test, found to have multifactorial pneumonia.   Acute respiratory failure with hypoxemia Abnormal CT chest  Multifocal pneumonia Respiratory failure in setting of pneumonia, likely combination of bacterial with component of COVID CTPA on admission without PE, though showed extensive bilateral lung opacity involving all lobes, most confluent in the left lung Initially required 4L supplemental O2, weaned to room air quickly Urinary antigens negative Sputum culture with mixed flora MRSA swab negative Pulm followed Initially on vanc/zosyn, transitioned to levofloxacin, planning 7 day course total Repeat CT chest in 6-8 weeks with outpatient pulmonology follow up   Sepsis, POA Lactic acidosis Due to pneumonia with leukocytosis, tachycardia, lactic acidosis on admission Blood cultures 2/2 with staph hominis, suspect contaminant Repeat blood cultures without growth at 48 hours Treated with antibiotics as above   CoNS positive blood cultures Blood cultures on admission 2 of 2 staph hominis, thought to be both contaminants given collection timing and not clinically relevant TTE does not show evidence of endocarditis ID followed Repeat blood cultures negative at 48 hours   Covid-19 Virus Infection Date of onset of symptoms: 3/10 Symptoms present on admission: Shortness of breath, fatigue Date of covid positive test: 3/12 on home antigen test, 3/15 here Vaccination status: vaccinated without booster Imaging: CTPA as above Oxygen requirements on admission: 4L nasal cannula Current oxygen requirements: room air Medical therapy: received steroids while admitted, discontinued on discharge given on room air and only briefly required oxygen;, was taking Paxlovid at home Consultants following: pulm Anticipated special isolation end date: 3/20   AKI Metabolic acidosis Admit Cr 2.1, baseline normal, suspect prerenal with ACEi use and was taking Paxlovid Improved renal function, back to baseline Resume ACEi/diuretic on discharge   Elevated LFTs In setting of COVID, though possibly related to remdesivir Improved to near normal Repeat 1 week   Hyponatremia Na 123, in setting of diminished intake, but was 126 Normalized   Anemia, normocytic Hgb 12.5, baseline wnl  Without evidence of active bleeding Iron studies with anemia of chronic disease Repeat as outpatient   Essential hypertension  Home regimen: amlodipine and lisinopril/hydrochlorothiazide  Held ACEi/diuretic during admission Resume home regimen on discharge
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Urine antigen test
Clinical narrative: Patient is a 54 y.o. male patient of MD with history of hypertension who presented to Hospital with shortness of breath, fatigue, recent COVID positive home test, found to have multifactorial pneumonia.   Acute respiratory failure with hypoxemia Abnormal CT chest  Multifocal pneumonia Respiratory failure in setting of pneumonia, likely combination of bacterial with component of COVID CTPA on admission without PE, though showed extensive bilateral lung opacity involving all lobes, most confluent in the left lung Initially required 4L supplemental O2, weaned to room air quickly Urinary antigens negative Sputum culture with mixed flora MRSA swab negative Pulm followed Initially on vanc/zosyn, transitioned to levofloxacin, planning 7 day course total Repeat CT chest in 6-8 weeks with outpatient pulmonology follow up   Sepsis, POA Lactic acidosis Due to pneumonia with leukocytosis, tachycardia, lactic acidosis on admission Blood cultures 2/2 with staph hominis, suspect contaminant Repeat blood cultures without growth at 48 hours Treated with antibiotics as above   CoNS positive blood cultures Blood cultures on admission 2 of 2 staph hominis, thought to be both contaminants given collection timing and not clinically relevant TTE does not show evidence of endocarditis ID followed Repeat blood cultures negative at 48 hours   Covid-19 Virus Infection Date of onset of symptoms: 3/10 Symptoms present on admission: Shortness of breath, fatigue Date of covid positive test: 3/12 on home antigen test, 3/15 here Vaccination status: vaccinated without booster Imaging: CTPA as above Oxygen requirements on admission: 4L nasal cannula Current oxygen requirements: room air Medical therapy: received steroids while admitted, discontinued on discharge given on room air and only briefly required oxygen;, was taking Paxlovid at home Consultants following: pulm Anticipated special isolation end date: 3/20   AKI Metabolic acidosis Admit Cr 2.1, baseline normal, suspect prerenal with ACEi use and was taking Paxlovid Improved renal function, back to baseline Resume ACEi/diuretic on discharge   Elevated LFTs In setting of COVID, though possibly related to remdesivir Improved to near normal Repeat 1 week   Hyponatremia Na 123, in setting of diminished intake, but was 126 Normalized   Anemia, normocytic Hgb 12.5, baseline wnl  Without evidence of active bleeding Iron studies with anemia of chronic disease Repeat as outpatient   Essential hypertension  Home regimen: amlodipine and lisinopril/hydrochlorothiazide  Held ACEi/diuretic during admission Resume home regimen on discharge